Loading...

ProPhase Labs, Inc.

PRPH•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$0.47
$0.04(10.56%)

ProPhase Labs, Inc. (PRPH) Stock Chart & Performance Analysis

Explore ProPhase Labs, Inc.’s stock chart, historical data, and performance trends for a deeper market understanding.

1-Day Change
-8.52%
5-Day Change
-21.04%
1-Month Change
-29.72%
3-Month Change
-58.78%
6-Month Change
-76.12%
Year-to-Date (YTD) Change
-69.60%
1-Year Change
-91.29%
3-Year Change
-93.40%
5-Year Change
-93.03%
All-Time (Max) Change
7.00%

Analyzing ProPhase Labs, Inc. (PRPH) Trends Across Multiple Time Frames

ProPhase Labs, Inc. Charts reveal critical insights by breaking down performance into different periods from short-term swings to long-term trends. ProPhase Labs, Inc. stock shows -8.52% 1-day change, indicating low volatility, while its 5-day change of -21.04% suggests a broader trend. Over a 1-month period, a -29.72% drop could signal a pullback, whereas a 3-month decline of -58.78% may reflect broader market sentiment. Longer timeframes help assess sustained performance. A 6-month change of -76.12% and a YTD drop of -69.60% might concern investors, but a 1-year loss of -91.29% and a 3-year drop of -93.40% could indicate resilience. The 5-year surge of -93.03% highlights weak historical growth, while the all-time return of 7.00% underscores long-term potential. Whether tracking intraday moves or multi-year trends, analyzing these metrics helps traders and investors make data-driven decisions.

Frequently Asked Questions

;